Published in Curr Diab Rep on December 01, 2014
Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease. Diabetes Care (2015) 1.25
4-methylumbelliferone treatment and hyaluronan inhibition as a therapeutic strategy in inflammation, autoimmunity, and cancer. Front Immunol (2015) 0.95
Hyaluronan: A Mediator of Islet Dysfunction and Destruction in Diabetes? J Histochem Cytochem (2015) 0.80
Regulation of hyaluronan synthesis in vascular diseases and diabetes. J Diabetes Res (2015) 0.79
Insulitis in the pathogenesis of type 1 diabetes. Pediatr Diabetes (2016) 0.75
Provisional matrix: A role for versican and hyaluronan. Matrix Biol (2016) 0.75
Endothelial basement membrane laminin 511 is essential for shear stress response. EMBO J (2016) 0.75
Editorial: Carbohydrates: The Yet to be Tasted Sweet Spot of Immunity. Front Immunol (2015) 0.75
A Combinatorial Protein Microarray for Probing Materials Interaction with Pancreatic Islet Cell Populations. Microarrays (Basel) (2016) 0.75
Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat Rev Immunol (2007) 17.18
Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem (1999) 11.87
The extracellular matrix: not just pretty fibrils. Science (2009) 8.52
Order out of chaos: assembly of ligand binding sites in heparan sulfate. Annu Rev Biochem (2001) 7.87
Stromal cell networks regulate lymphocyte entry, migration, and territoriality in lymph nodes. Immunity (2006) 7.22
Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer (2004) 6.47
A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med (2006) 5.05
Hyaluronan: its nature, distribution, functions and turnover. J Intern Med (1997) 4.55
The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat Rev Endocrinol (2009) 4.36
Resolution of lung inflammation by CD44. Science (2002) 4.09
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion. Genes Dev (2010) 3.56
The extracellular matrix at a glance. J Cell Sci (2010) 3.37
High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat. Nature (2013) 3.32
Hyaluronan fragments: an information-rich system. Eur J Cell Biol (2006) 3.26
Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development (2004) 3.12
The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell (2006) 3.10
Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis. J Clin Invest (2001) 2.98
Heparan sulfate proteoglycans. Cold Spring Harb Perspect Biol (2011) 2.96
Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol (2009) 2.93
Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med (2012) 2.86
Hyaluronan as an immune regulator in human diseases. Physiol Rev (2011) 2.74
The role of heparan sulphate in inflammation. Nat Rev Immunol (2006) 2.51
Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev (2006) 2.47
The impact of the extracellular matrix on inflammation. Nat Rev Immunol (2010) 2.30
Recombinant nidogen consists of three globular domains and mediates binding of laminin to collagen type IV. EMBO J (1991) 2.23
Hyaluronan-binding proteins: tying up the giant. J Biol Chem (2001) 2.20
Unique structural features that influence neutrophil emigration into the lung. Physiol Rev (2003) 2.13
Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J Exp Med (2006) 2.13
Laminins. Cell Tissue Res (2009) 2.01
Endothelial cell laminin isoforms, laminins 8 and 10, play decisive roles in T cell recruitment across the blood-brain barrier in experimental autoimmune encephalomyelitis. J Cell Biol (2001) 1.98
The structure and function of hyaluronan: An overview. Immunol Cell Biol (1996) 1.84
Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors. J Biol Chem (2005) 1.79
Hyaluronan cross-linking: a protective mechanism in inflammation? Trends Immunol (2005) 1.77
Development of a peptide inhibitor of hyaluronan-mediated leukocyte trafficking. J Exp Med (2000) 1.65
Matrix metalloproteinase proteomics: substrates, targets, and therapy. Curr Opin Cell Biol (2009) 1.65
TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J Biol Chem (2004) 1.48
Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes. J Clin Invest (2011) 1.47
Missing the target: matrix metalloproteinase antitargets in inflammation and cancer. Trends Pharmacol Sci (2013) 1.47
The Juvenile Diabetes Research Foundation Network for Pancreatic Organ Donors with Diabetes (nPOD) Program: goals, operational model and emerging findings. Pediatr Diabetes (2013) 1.46
Laminins in basement membrane assembly. Cell Adh Migr (2012) 1.44
Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am J Pathol (2007) 1.43
Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia (2008) 1.41
Hyaluronan matrices in pathobiological processes. FEBS J (2011) 1.40
Pathophysiology of heparan sulphate: many diseases, few drugs. J Intern Med (2013) 1.38
Blood vessels of human islets of Langerhans are surrounded by a double basement membrane. Diabetologia (2008) 1.37
Nidogen mediates the formation of ternary complexes of basement membrane components. Kidney Int (1993) 1.37
VEGF-A induces angiogenesis by perturbing the cathepsin-cysteine protease inhibitor balance in venules, causing basement membrane degradation and mother vessel formation. Cancer Res (2009) 1.32
Microcirculation of the islets of Langerhans. Long Beach Veterans Administration Regional Medical Education Center Symposium. Diabetes (1996) 1.32
Unique basement membrane structure of human pancreatic islets: implications for beta-cell growth and differentiation. Diabetes Obes Metab (2008) 1.28
The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes (2012) 1.27
Role, metabolism, chemical modifications and applications of hyaluronan. Curr Med Chem (2009) 1.26
Heparan sulfate biosynthesis: regulation and variability. J Histochem Cytochem (2012) 1.25
The inflammation-associated protein TSG-6 cross-links hyaluronan via hyaluronan-induced TSG-6 oligomers. J Biol Chem (2011) 1.23
Glucans exhibit weak antioxidant activity, but stimulate macrophage free radical activity. Free Radic Biol Med (2001) 1.22
Induction of resistance to diabetes in non-obese diabetic mice by targeting CD44 with a specific monoclonal antibody. Proc Natl Acad Sci U S A (2000) 1.20
The pancreas in human type 1 diabetes: providing new answers to age-old questions. Curr Opin Endocrinol Diabetes Obes (2009) 1.16
Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol (2011) 1.15
TSG-6 produced by hMSCs delays the onset of autoimmune diabetes by suppressing Th1 development and enhancing tolerogenicity. Diabetes (2013) 1.13
The turnover of basal lamina glycosaminoglycan correlates with epithelial morphogenesis. Dev Biol (1982) 1.12
Distinct distribution of laminin and its integrin receptors in the pancreas. J Histochem Cytochem (2002) 1.11
Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am J Respir Cell Mol Biol (2009) 1.10
Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med (2009) 1.10
Synthesis and surface expression of hyaluronan by dendritic cells and its potential role in antigen presentation. J Immunol (2002) 1.09
Threat matrix: low-molecular-weight hyaluronan (HA) as a danger signal. Immunol Res (2005) 1.09
The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem (2012) 1.04
The pathogenesis of diabetes in the NOD mouse. Adv Immunol (2004) 1.02
Structural and genetic analysis of laminin-nidogen interaction. Ann N Y Acad Sci (1998) 1.00
Proliferation and plasticity of human beta cells on physiologically occurring laminin isoforms. Mol Cell Endocrinol (2012) 1.00
Immunologic roles of hyaluronan. Immunol Res (2005) 1.00
Hyaluronate is costimulatory for human T cell effector functions and binds to CD44 on activated T cells. J Immunol (1994) 0.99
Important role of heparan sulfate in postnatal islet growth and insulin secretion. Biochem Biophys Res Commun (2009) 0.96
The role of hyaluronan and the extracellular matrix in islet inflammation and immune regulation. Curr Diab Rep (2012) 0.96
Hyaluronan in intestinal homeostasis and inflammation: implications for fibrosis. Am J Physiol Gastrointest Liver Physiol (2011) 0.94
Autoimmune diabetes: the involvement of benign and malignant autoimmunity. J Autoimmun (1999) 0.94
Sites of nidogen cleavage by proteases involved in tissue homeostasis and remodelling. Eur J Biochem (1993) 0.94
Th1 cytokines promote T-cell binding to antigen-presenting cells via enhanced hyaluronan production and accumulation at the immune synapse. Cell Mol Immunol (2010) 0.94
Distribution of collagens type I, type III and type V in the pancreas of rat, dog, pig and man. Cell Tissue Res (1994) 0.93
Hyaluronan and hyaluronan-binding proteins accumulate in both human type 1 diabetic islets and lymphoid tissues and associate with inflammatory cells in insulitis. Diabetes (2014) 0.92
Clinical studies. Trying to reset the clock on type 1 diabetes. Science (2011) 0.91
Matricryptins and matrikines: biologically active fragments of the extracellular matrix. Exp Dermatol (2014) 0.90
Inter-α-inhibitor impairs TSG-6-induced hyaluronan cross-linking. J Biol Chem (2013) 0.90
Immune cell recruitment to inflammatory loci is impaired in mice deficient in basement membrane protein laminin alpha4. J Leukoc Biol (2010) 0.88
Current concepts of extracellular matrix. J Orthop Sci (2006) 0.88
Vascular endothelial growth factor coordinates islet innervation via vascular scaffolding. Development (2014) 0.84
Biological effects of hyaluronan in connective tissues, eye, skin, venous wall. Role in aging. Pathol Biol (Paris) (2009) 0.83
Immunohistochemical study of the pancreatic basement membrane in non obese diabetic mice (NOD) with spontaneous autoimmune insulitis. J Submicrosc Cytol Pathol (2003) 0.82
Extracellular signals and pancreatic beta-cell development: a brief review. Mol Med (2002) 0.79
Hypotheses on the evolution of hyaluronan: a highly ironic acid. Glycobiology (2013) 0.78
The CLIP-CHIP oligonucleotide microarray: dedicated array for analysis of all protease, nonproteolytic homolog, and inhibitor gene transcripts in human and mouse. Curr Protoc Protein Sci (2007) 0.77
Immunomodulators: Cell savers. Nature (2012) 0.77
The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity (2009) 7.69
The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. Immunity (2005) 4.72
Monitoring lymphocyte proliferation in vitro and in vivo with the intracellular fluorescent dye carboxyfluorescein diacetate succinimidyl ester. Nat Protoc (2007) 3.45
Human tissue-engineered blood vessels for adult arterial revascularization. Nat Med (2006) 3.39
The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell (2006) 3.10
DNAzyme targeting c-jun suppresses skin cancer growth. Sci Transl Med (2012) 3.09
Early human atherosclerosis: accumulation of lipid and proteoglycans in intimal thickenings followed by macrophage infiltration. Arterioscler Thromb Vasc Biol (2007) 2.58
Hyaluronan-cell interactions in cancer and vascular disease. J Biol Chem (2001) 2.45
Integrin-alpha9 is required for fibronectin matrix assembly during lymphatic valve morphogenesis. Dev Cell (2009) 2.41
Progressive vascular smooth muscle cell defects in a mouse model of Hutchinson-Gilford progeria syndrome. Proc Natl Acad Sci U S A (2006) 2.28
Immobilized chemokine fields and soluble chemokine gradients cooperatively shape migration patterns of dendritic cells. Immunity (2010) 2.18
Venular basement membranes contain specific matrix protein low expression regions that act as exit points for emigrating neutrophils. J Exp Med (2006) 2.13
The blood-brain and the blood-cerebrospinal fluid barriers: function and dysfunction. Semin Immunopathol (2009) 2.12
Characterization of ADAMTS-9 and ADAMTS-20 as a distinct ADAMTS subfamily related to Caenorhabditis elegans GON-1. J Biol Chem (2003) 2.10
SPARC-null mice display abnormalities in the dermis characterized by decreased collagen fibril diameter and reduced tensile strength. J Invest Dermatol (2003) 1.98
Cardiovascular pathology in Hutchinson-Gilford progeria: correlation with the vascular pathology of aging. Arterioscler Thromb Vasc Biol (2010) 1.96
Adipocyte-derived serum amyloid A3 and hyaluronan play a role in monocyte recruitment and adhesion. Diabetes (2007) 1.95
Enhanced extracellular matrix accumulation in restenosis of coronary arteries after stent deployment. J Am Coll Cardiol (2002) 1.92
Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc Natl Acad Sci U S A (2012) 1.91
Extracellular matrix molecules: potential targets in pharmacotherapy. Pharmacol Rev (2009) 1.90
Maintenance of chondroitin sulfation balance by chondroitin-4-sulfotransferase 1 is required for chondrocyte development and growth factor signaling during cartilage morphogenesis. Development (2005) 1.88
Transforming growth factor beta 1 induces neointima formation through plasminogen activator inhibitor-1-dependent pathways. Arterioscler Thromb Vasc Biol (2005) 1.87
Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin. Invest Ophthalmol Vis Sci (2002) 1.82
Deletion of the laminin alpha4 chain leads to impaired microvessel maturation. Mol Cell Biol (2002) 1.81
The ADAMTS proteases, extracellular matrix, and vascular disease: waking the sleeping giant(s)! Arterioscler Thromb Vasc Biol (2005) 1.76
Hyaluronan-dependent pericellular matrix. Adv Drug Deliv Rev (2007) 1.73
The enlarged population of marginal zone/CD1d(high) B lymphocytes in nonobese diabetic mice maps to diabetes susceptibility region Idd11. J Immunol (2005) 1.72
The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD8+ T cells. Nat Med (2010) 1.70
Reversal of the glycolytic phenotype by dichloroacetate inhibits metastatic breast cancer cell growth in vitro and in vivo. Breast Cancer Res Treat (2009) 1.69
Intracellular hyaluronan: a new frontier for inflammation? Biochim Biophys Acta (2004) 1.64
Increase in serum amyloid a evoked by dietary cholesterol is associated with increased atherosclerosis in mice. Circulation (2004) 1.61
Autocrine purinergic receptor signaling is essential for macrophage chemotaxis. Sci Signal (2010) 1.52
Heparan sulfate and heparanase play key roles in mouse β cell survival and autoimmune diabetes. J Clin Invest (2011) 1.47
Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans. Cardiovasc Res (2008) 1.44
Serum amyloid A and lipoprotein retention in murine models of atherosclerosis. Arterioscler Thromb Vasc Biol (2005) 1.43
A functional heparan sulfate mimetic implicates both heparanase and heparan sulfate in tumor angiogenesis and invasion in a mouse model of multistage cancer. Oncogene (2005) 1.43
Endothelial basement membrane limits tip cell formation by inducing Dll4/Notch signalling in vivo. EMBO Rep (2011) 1.40
Triglyceride-rich lipoproteins from subjects with type 2 diabetes do not demonstrate increased binding to biglycan, a vascular proteoglycan. J Clin Endocrinol Metab (2002) 1.38
Cutting edge: high molecular weight hyaluronan promotes the suppressive effects of CD4+CD25+ regulatory T cells. J Immunol (2007) 1.38
The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr (2004) 1.36
Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol (2007) 1.36
A role for decorin in cutaneous wound healing and angiogenesis. Wound Repair Regen (2006) 1.33
Histidine-rich glycoprotein: A novel adaptor protein in plasma that modulates the immune, vascular and coagulation systems. Immunol Cell Biol (2005) 1.32
Extracellular matrix changes in stented human coronary arteries. Circulation (2004) 1.32
New and improved methods for measuring lymphocyte proliferation in vitro and in vivo using CFSE-like fluorescent dyes. J Immunol Methods (2012) 1.32
Differential accumulation of proteoglycans and hyaluronan in culprit lesions: insights into plaque erosion. Arterioscler Thromb Vasc Biol (2002) 1.31
Dynamic histone variant exchange accompanies gene induction in T cells. Mol Cell Biol (2009) 1.31
Glycosaminoglycans and proteoglycans in normal mitral valve leaflets and chordae: association with regions of tensile and compressive loading. Glycobiology (2004) 1.30
CD44 costimulation promotes FoxP3+ regulatory T cell persistence and function via production of IL-2, IL-10, and TGF-beta. J Immunol (2009) 1.28
The peri-islet basement membrane, a barrier to infiltrating leukocytes in type 1 diabetes in mouse and human. Diabetes (2012) 1.27
Overexpression of the V3 variant of versican alters arterial smooth muscle cell adhesion, migration, and proliferation in vitro. J Cell Physiol (2002) 1.27
Alternative splice variants of alpha 7 beta 1 integrin selectively recognize different laminin isoforms. J Biol Chem (2001) 1.25
Inhibition of versican synthesis by antisense alters smooth muscle cell phenotype and induces elastic fiber formation in vitro and in neointima after vessel injury. Circ Res (2005) 1.24
Kinetics of chemokine-glycosaminoglycan interactions control neutrophil migration into the airspaces of the lungs. J Immunol (2010) 1.23
Versican degradation and vascular disease. Trends Cardiovasc Med (2006) 1.23
Cerebral vessel laminins and IFN-gamma define Trypanosoma brucei brucei penetration of the blood-brain barrier. J Clin Invest (2004) 1.23
Changes in elastin, elastin binding protein and versican in alveoli in chronic obstructive pulmonary disease. Respir Res (2008) 1.22
Targeting dendritic cells with antigen-containing liposomes: a highly effective procedure for induction of antitumor immunity and for tumor immunotherapy. Cancer Res (2004) 1.21
Retrovirally mediated overexpression of versican v3 reverses impaired elastogenesis and heightened proliferation exhibited by fibroblasts from Costello syndrome and Hurler disease patients. Am J Pathol (2004) 1.21
Decorin-mediated regulation of fibrillin-1 in the kidney involves the insulin-like growth factor-I receptor and Mammalian target of rapamycin. Am J Pathol (2007) 1.20
Intact extracellular matrix and the maintenance of immune tolerance: high molecular weight hyaluronan promotes persistence of induced CD4+CD25+ regulatory T cells. J Leukoc Biol (2009) 1.20
Modulation of pancreatic islets-stress axis by hypothalamic releasing hormones and 11beta-hydroxysteroid dehydrogenase. Proc Natl Acad Sci U S A (2011) 1.20
Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts. Am J Respir Cell Mol Biol (2004) 1.18
Alterations in the lens capsule contribute to cataractogenesis in SPARC-null mice. J Cell Sci (2002) 1.17
ECM components guide IL-10 producing regulatory T-cell (TR1) induction from effector memory T-cell precursors. Proc Natl Acad Sci U S A (2011) 1.17
Binding of interleukin-8 to heparan sulfate and chondroitin sulfate in lung tissue. Am J Respir Cell Mol Biol (2003) 1.17
CD99 and CD99L2 act at the same site as, but independently of, PECAM-1 during leukocyte diapedesis. Blood (2010) 1.16
Sialoadhesin-positive macrophages bind regulatory T cells, negatively controlling their expansion and autoimmune disease progression. J Immunol (2009) 1.16
Chromatin-associated protein kinase C-θ regulates an inducible gene expression program and microRNAs in human T lymphocytes. Mol Cell (2011) 1.15
Heparan sulfate in perlecan promotes mouse atherosclerosis: roles in lipid permeability, lipid retention, and smooth muscle cell proliferation. Circ Res (2008) 1.15
Hyaluronan and versican in the control of human T-lymphocyte adhesion and migration. Matrix Biol (2011) 1.15
The use of carboxyfluorescein diacetate succinimidyl ester (CFSE) to monitor lymphocyte proliferation. J Vis Exp (2010) 1.14
A novel rat model of carotid artery stenting for the understanding of restenosis in metabolic diseases. J Vasc Res (2002) 1.14
Organization of hyaluronan and versican in the extracellular matrix of human fibroblasts treated with the viral mimetic poly I:C. J Histochem Cytochem (2009) 1.13
Overexpression of hyaluronan synthases alters vascular smooth muscle cell phenotype and promotes monocyte adhesion. J Cell Physiol (2006) 1.13
Laminin isoforms in endothelial and perivascular basement membranes. Cell Adh Migr (2012) 1.13
Proteoglycans synthesized by arterial smooth muscle cells in the presence of transforming growth factor-beta1 exhibit increased binding to LDLs. Arterioscler Thromb Vasc Biol (2002) 1.11
Polyinosine-polycytidylic acid stimulates versican accumulation in the extracellular matrix promoting monocyte adhesion. Am J Respir Cell Mol Biol (2009) 1.10
Endothelial basement membrane laminin alpha5 selectively inhibits T lymphocyte extravasation into the brain. Nat Med (2009) 1.10
Phosphomannopentaose sulfate (PI-88): heparan sulfate mimetic with clinical potential in multiple vascular pathologies. Cardiovasc Drug Rev (2004) 1.10
Matricellular hevin regulates decorin production and collagen assembly. J Biol Chem (2006) 1.09
Interplay between chromatin remodeling and epigenetic changes during lineage-specific commitment to granzyme B expression. J Immunol (2009) 1.09
Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans. Arterioscler Thromb Vasc Biol (2011) 1.08
Intracellular hyaluronan in arterial smooth muscle cells: association with microtubules, RHAMM, and the mitotic spindle. J Histochem Cytochem (2004) 1.07
Developing vasculature and stroma in engineered human myocardium. Tissue Eng Part A (2011) 1.07
Bystander B cells rapidly acquire antigen receptors from activated B cells by membrane transfer. Proc Natl Acad Sci U S A (2008) 1.07
Proteoglycans: key regulators of pulmonary inflammation and the innate immune response to lung infection. Anat Rec (Hoboken) (2010) 1.06
Lung lining fluid glutathione attenuates IL-13-induced asthma. Am J Respir Cell Mol Biol (2007) 1.06
Synthesis and organization of hyaluronan and versican by embryonic stem cells undergoing embryoid body differentiation. J Histochem Cytochem (2009) 1.05
The low molecular weight heparan sulfate-mimetic, PI-88, inhibits cell-to-cell spread of herpes simplex virus. Antiviral Res (2004) 1.05
Motorized RhoGAP myosin IXb (Myo9b) controls cell shape and motility. Proc Natl Acad Sci U S A (2010) 1.05
The epidermal basement membrane is a composite of separate laminin- or collagen IV-containing networks connected by aggregated perlecan, but not by nidogens. J Biol Chem (2012) 1.04
Dramatic regulation of heparanase activity and angiogenesis gene expression in synovium from patients with rheumatoid arthritis. Arthritis Rheum (2008) 1.03
Monocyte-to-macrophage differentiation: synthesis and secretion of a complex extracellular matrix. J Biol Chem (2012) 1.02
Eotaxin selectively binds heparin. An interaction that protects eotaxin from proteolysis and potentiates chemotactic activity in vivo. J Biol Chem (2007) 1.02
Changes in perlecan expression during vascular injury: role in the inhibition of smooth muscle cell proliferation in the late lesion. Arterioscler Thromb Vasc Biol (2003) 1.01
Diabetes and arterial extracellular matrix changes in a porcine model of atherosclerosis. J Histochem Cytochem (2007) 1.01